Short Interest in Lifeward Ltd. (NASDAQ:LFWD) Declines By 24.5%

Lifeward Ltd. (NASDAQ:LFWD) saw a significant decrease in short interest in March. As of March 31st, there was short interest totaling 157,182 shares, a decrease of 24.5% from the March 15th total of 208,221 shares. Based on an average daily volume of 13,323 shares, the days-to-cover ratio is currently 11.8 days. Approximately 10.4% of the shares of the stock are sold short.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on LFWD. HC Wainwright boosted their target price on shares of Lifeward to $10.00 and gave the stock a “buy” rating in a report on Thursday, March 19th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Lifeward in a report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $10.00.

Lifeward Stock Up 0.6%

LFWD traded up $0.04 during trading on Thursday, reaching $6.68. The company had a trading volume of 3,997 shares, compared to its average volume of 8,692. The business has a 50 day simple moving average of $6.45 and a 200-day simple moving average of $7.31. The stock has a market cap of $10.22 million, a P/E ratio of -0.36 and a beta of 0.16. Lifeward has a 52 week low of $4.14 and a 52 week high of $18.60.

Lifeward (NASDAQ:LFWD) last posted its quarterly earnings data on Thursday, March 19th. The company reported ($3.60) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.07) by ($3.53). The firm had revenue of $5.08 million for the quarter, compared to the consensus estimate of $7.87 million. Lifeward had a negative net margin of 90.38% and a negative return on equity of 145.55%. As a group, equities research analysts expect that Lifeward will post -1.78 EPS for the current fiscal year.

Institutional Trading of Lifeward

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in LFWD. Citadel Advisors LLC boosted its position in shares of Lifeward by 1,271.8% during the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after buying an additional 198,406 shares during the period. Virtu Financial LLC raised its holdings in shares of Lifeward by 158.0% in the fourth quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after buying an additional 37,037 shares during the period. Jane Street Group LLC raised its holdings in shares of Lifeward by 77.3% in the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after buying an additional 29,927 shares during the period. Finally, HRT Financial LP lifted its stake in shares of Lifeward by 149.7% during the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after acquiring an additional 29,423 shares during the last quarter. 26.76% of the stock is owned by hedge funds and other institutional investors.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.